Inge-Marie Obdeijn

1.4k total citations
18 papers, 835 citations indexed

About

Inge-Marie Obdeijn is a scholar working on Genetics, Cancer Research and Oncology. According to data from OpenAlex, Inge-Marie Obdeijn has authored 18 papers receiving a total of 835 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Genetics, 12 papers in Cancer Research and 7 papers in Oncology. Recurrent topics in Inge-Marie Obdeijn's work include BRCA gene mutations in cancer (13 papers), Global Cancer Incidence and Screening (7 papers) and Breast Cancer Treatment Studies (6 papers). Inge-Marie Obdeijn is often cited by papers focused on BRCA gene mutations in cancer (13 papers), Global Cancer Incidence and Screening (7 papers) and Breast Cancer Treatment Studies (6 papers). Inge-Marie Obdeijn collaborates with scholars based in Netherlands, United States and Australia. Inge-Marie Obdeijn's co-authors include Madeleine M.A. Tilanus‐Linthorst, Cecile T.M. Brekelmans, Theodorus van der Kwast, Vibeke Kuenen‐Boumeester, A.Y. de Kanter, M. Menke-Pluymers, Caroline Seynaeve, A.N. van Geel, L.C. Verhoog and E.J. Meijers-Heijboer and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Clinical Cancer Research.

In The Last Decade

Inge-Marie Obdeijn

17 papers receiving 811 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Inge-Marie Obdeijn Netherlands	13	413	359	324	263	255	18	835
Sepideh Saadatmand Netherlands	10	279 0.7×	170 0.5×	154 0.5×	322 1.2×	156 0.6×	14	648
Melissa Pilewskie United States	18	761 1.8×	532 1.5×	160 0.5×	385 1.5×	167 0.7×	54	1.0k
Andrea Sagona Italy	14	418 1.0×	258 0.7×	92 0.3×	206 0.8×	215 0.8×	41	708
Pietro Panizza Italy	11	348 0.8×	327 0.9×	65 0.2×	232 0.9×	432 1.7×	45	865
F. Laki France	14	475 1.2×	278 0.8×	72 0.2×	216 0.8×	90 0.4×	40	658
D.M. Sibbering United Kingdom	15	326 0.8×	237 0.7×	115 0.4×	363 1.4×	82 0.3×	35	706
Iwa Kong Canada	12	472 1.1×	214 0.6×	56 0.2×	196 0.7×	100 0.4×	29	597
Jennifer Chun United States	14	286 0.7×	220 0.6×	69 0.2×	311 1.2×	163 0.6×	46	719
Elizabeth R. DePeri United States	11	411 1.0×	510 1.4×	90 0.3×	148 0.6×	598 2.3×	13	992
Loes Kooreman Netherlands	15	202 0.5×	140 0.4×	58 0.2×	135 0.5×	158 0.6×	52	558

Countries citing papers authored by Inge-Marie Obdeijn

Since Specialization

Citations

This map shows the geographic impact of Inge-Marie Obdeijn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inge-Marie Obdeijn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inge-Marie Obdeijn more than expected).

Fields of papers citing papers by Inge-Marie Obdeijn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Inge-Marie Obdeijn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inge-Marie Obdeijn. The network helps show where Inge-Marie Obdeijn may publish in the future.

Co-authorship network of co-authors of Inge-Marie Obdeijn

This figure shows the co-authorship network connecting the top 25 collaborators of Inge-Marie Obdeijn. A scholar is included among the top collaborators of Inge-Marie Obdeijn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Inge-Marie Obdeijn. Inge-Marie Obdeijn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Heemskerk-Gerritsen, B.A.M., Inge-Marie Obdeijn, Linetta B. Koppert, et al.. (2022). Survival of BRCA1/BRCA2-associated pT1 breast cancer patients, a cohort study. Breast Cancer Research and Treatment. 194(1). 159–170.

Geuzinge, H. Amarens, Eveline A.M. Heijnsdijk, Inge-Marie Obdeijn, Harry J. de Koning, & Madeleine M.A. Tilanus‐Linthorst. (2021). Experiences, expectations and preferences regarding MRI and mammography as breast cancer screening tools in women at familial risk. The Breast. 56. 1–6. 11 indexed citations

Obdeijn, Inge-Marie, Ritse M. Mann, Marc B. I. Lobbes, et al.. (2020). The supplemental value of mammographic screening over breast MRI alone in BRCA2 mutation carriers. Breast Cancer Research and Treatment. 181(3). 581–588. 9 indexed citations

Geuzinge, H. Amarens, Inge-Marie Obdeijn, Emiel J. Rutgers, et al.. (2020). Cost-effectiveness of Breast Cancer Screening With Magnetic Resonance Imaging for Women at Familial Risk. JAMA Oncology. 6(9). 1381–1381. 34 indexed citations

Greuter, Marcel J. W., Inge-Marie Obdeijn, Jan C. Oosterwijk, et al.. (2019). Should women with a BRCA1/2 mutation aged 60 and older be offered intensified breast cancer screening? – A cost-effectiveness analysis. The Breast. 45. 82–88. 9 indexed citations

Obdeijn, Inge-Marie, Eveline A.M. Heijnsdijk, M. G. Myriam Hunink, Madeleine M.A. Tilanus‐Linthorst, & Harry J. de Koning. (2016). Mammographic screening in BRCA1 mutation carriers postponed until age 40: Evaluation of benefits, costs and radiation risks using models. European Journal of Cancer. 63. 135–142. 15 indexed citations

Vos, Elvira L., Adri C. Voogd, Cornelis Verhoef, et al.. (2015). Benefits of preoperative MRI in breast cancer surgery studied in a large population-based cancer registry. British journal of surgery. 102(13). 1649–1657. 28 indexed citations

Heemskerk-Gerritsen, B.A.M., Rob B. van der Luijt, Inge-Marie Obdeijn, et al.. (2014). Lower mitotic activity in BRCA1/2-associated primary breast cancers occurring after risk-reducing salpingo-oophorectomy. Cancer Biology & Therapy. 15(4). 371–379. 5 indexed citations

Obdeijn, Inge-Marie, et al.. (2014). Should we screen BRCA1 mutation carriers only with MRI? A multicenter study. Breast Cancer Research and Treatment. 144(3). 577–582. 46 indexed citations

10.

Vos, Elvira L., Anton H. J. Koning, Inge-Marie Obdeijn, et al.. (2014). Preoperative prediction of cosmetic results in breast conserving surgery. Journal of Surgical Oncology. 111(2). 178–184. 33 indexed citations

11.

Saadatmand, Sepideh, Madeleine M.A. Tilanus‐Linthorst, Emiel J. Rutgers, et al.. (2013). Cost-Effectiveness of Screening Women With Familial Risk for Breast Cancer With Magnetic Resonance Imaging. JNCI Journal of the National Cancer Institute. 105(17). 1314–1321. 54 indexed citations

12.

Obdeijn, Inge-Marie, Madeleine M.A. Tilanus‐Linthorst, Sandra Spronk, et al.. (2013). Preoperative Breast MRI Can Reduce the Rate of Tumor-Positive Resection Margins and Reoperations in Patients Undergoing Breast-Conserving Surgery. American Journal of Roentgenology. 200(2). 304–310. 51 indexed citations

13.

Saadatmand, Sepideh, Emiel J. Rutgers, Linetta B. Koppert, et al.. (2012). Breast density as indicator for the use of mammography or MRI to screen women with familial risk for breast cancer (FaMRIsc): a multicentre randomized controlled trial. BMC Cancer. 12(1). 440–440. 15 indexed citations

14.

Bakker, Jurriaan F., Margarethus M. Paulides, Inge-Marie Obdeijn, Gerard C. van Rhoon, & Koen W. A. van Dongen. (2009). An ultrasound cylindrical phased array for deep heating in the breast: theoretical design using heterogeneous models. Physics in Medicine and Biology. 54(10). 3201–3215. 36 indexed citations

15.

Tilanus‐Linthorst, Madeleine M.A., Inge-Marie Obdeijn, Wim C.J. Hop, et al.. (2007). BRCA1 Mutation and Young Age Predict Fast Breast Cancer Growth in the Dutch, United Kingdom, and Canadian Magnetic Resonance Imaging Screening Trials. Clinical Cancer Research. 13(24). 7357–7362. 73 indexed citations

16.

Tilanus‐Linthorst, Madeleine M.A., Mieke Kriege, C. Boetes, et al.. (2005). Hereditary breast cancer growth rates and its impact on screening policy. European Journal of Cancer. 41(11). 1610–1617. 58 indexed citations

17.

Kuenen‐Boumeester, Vibeke, et al.. (2002). Ultrasound-guided fine needle aspiration cytology of axillary lymph nodes in breast cancer patients. A preoperative staging procedure. European Journal of Cancer. 39(2). 170–174. 125 indexed citations

18.

Brekelmans, Cecile T.M., Caroline Seynaeve, C.C.M. Bartels, et al.. (2001). Effectiveness of Breast Cancer Surveillance in BRCA1/2 Gene Mutation Carriers and Women With High Familial Risk. Journal of Clinical Oncology. 19(4). 924–930. 233 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact